Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling

  • María D Cuenca-López1,
  • Juan C Montero2,
  • Jorge C Morales1,
  • Aleix Prat3,
  • Atanasio Pandiella2 and
  • Alberto Ocana1Email author
BMC Cancer201414:302

DOI: 10.1186/1471-2407-14-302

Received: 20 May 2013

Accepted: 17 April 2014

Published: 30 April 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 May 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
11 Jul 2013 Reviewed Reviewer Report - Ja Seung Koo
17 Jul 2013 Reviewed Reviewer Report - Seho Park
6 Feb 2014 Reviewed Reviewer Report - Jason Carroll
18 Mar 2014 Author responded Author comments - Maria D Cuenca
Resubmission - Version 5
18 Mar 2014 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
19 Mar 2014 Author responded Author comments - Maria D Cuenca
Resubmission - Version 7
19 Mar 2014 Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
25 Mar 2014 Reviewed Reviewer Report - Jason Carroll
Resubmission - Version 10
Submitted Manuscript version 10
Publishing
17 Apr 2014 Editorially accepted
30 Apr 2014 Article published 10.1186/1471-2407-14-302

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Translational Cancer Research Unit, Albacete University Hospital
(2)
Salamanca Cancer Research Center-CSIC
(3)
Vall D’Hebron Institute of Oncology (VHIO)

Advertisement